Disease: Endometrial Carcinoma ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0476089
Disease: Endometrial Carcinoma
Endometrial Carcinoma 		0.050 Biomarker disease BEFREE We establish that miR-365-EZH2/FOS pathway is an important target for treating EC. 30464615 2018
CUI: C0476089
Disease: Endometrial Carcinoma
Endometrial Carcinoma 		0.050 AlteredExpression disease BEFREE Higher levels of AP-1 components are present in breast and endometrial carcinomas, colorectal cancer and in acute myeloid leukemia, Hodgkin׳s lymphoma and anaplastic large cell lymphoma, with downregulation in ovarian and gastric carcinomas and in patients with chronic myelogenous leukemia. 28502334 2017
CUI: C0476089
Disease: Endometrial Carcinoma
Endometrial Carcinoma 		0.050 Biomarker disease BEFREE In addition, CDK1, CCNA2, JUN, and FOS might play important roles in EC development. 26437953 2016
CUI: C0476089
Disease: Endometrial Carcinoma
Endometrial Carcinoma 		0.050 Biomarker disease BEFREE The microRNA-101-EZH2/MCL-1/FOS axis is a potential therapeutic target for endometrial cancer. 25153722 2014
CUI: C0476089
Disease: Endometrial Carcinoma
Endometrial Carcinoma 		0.050 AlteredExpression disease BEFREE Treatment of Ishikawa and Hec-1A human endometrial cancer cells with 100 nM triptorelin resulted in a 3.1-fold and 3.5-fold activation of AP-1 respectively (P<0.05). 11720885 2001